APPLICATIONS OF MULTIMODAL GENERATIVE ARTIFICIAL INTELLIGENCE IN A REAL-WORLD RETINA CLINIC SETTING

Macular Diseases

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database

Br J Ophthalmol

Martin-Pinardel R, Izquierdo-Serra J, Bernal-Morales C, De Zanet S, Garay-Aramburu G, Puzo M, Arruabarrena C, Sararols L, Abraldes M, Broc L, Escobar-Barranco JJ, Figueroa M, Zapata MA, Ruiz-Moreno JM, Parrado-Carrillo A, Moll-Udina A, Alforja S, Figueras-Roca M, Gómez-Baldó L, Ciller C, Apostolopoulos S, Mishchuk A, Casaroli-Marano RP, Zarranz-Ventura J, from the FRB SPAIN-IMAGE Project Investigators

doi: 10.1136/bjo-2024-325615

Retinal Diseases

Performance of artificial intelligence-based models for epiretinal membrane diagnosis: A systematic review and meta-analysis

Am J Ophthalmol

Mikhail D, Gao A, Farah A, Mihalache A, Milad D, Antaki F, Popovic MM, Shor R, Duval R, Kertes PJ, Kohly RP, Muni RH

doi: 10.1016/j.ajo.2025.05.041

Uveitis

Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes

Retina

Montesel A, Sen S, Preston E, Patel PJ, Huemer J, Hamilton RD, Nicholson L, Papasavvas I, Tucker WR, Yeung I

doi: 10.1097/IAE.0000000000004394

Glaucoma and Ocular Pressure

Prototype master protocol for benchmarking of real-world follow-up data in glaucoma

Acta Ophthalmol

Hujanen P, Tuulonen A, Leinonen S, Vepsäläinen K, Jóhannesson G, Vaajanen A, Lehtonen E, Uusitalo-Jarvinen H

doi: 10.1111/aos.17453

Macular DiseasesFurther Publications

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

Ophthalmol Sci

Mulyukov Z, Keane PA, Sahni J, Liakopoulos S, Hatz K, Wei Ting DS, Gallego-Pinazo R, Aslam T, Gemmy Cheung CM, De Salvo G, Semoun O, Somfai GM, Stahl A, Lujan BJ, Lorand D

doi: 10.1016/j.xops.2024.100565

Macular Diseases

The role of artificial intelligence in macular hole management: A scoping review

Surv Ophthalmol

Mikhail D, Milad D, Antaki F, Hammamji K, Qian CX, Rezende FA, Duval R

doi: 10.1016/j.survophthal.2024.09.003

Macular Diseases

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study

Int J Retina Vitreous

Grimaldi G, Cancian G, Paris A, Clerici M, Volpe G, Menghini M

doi: 10.1186/s40942-024-00586-w

Macular Diseases

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

J Clin Med

Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest

doi: 10.3390/jcm13237336

Macular DiseasesFurther Publications

Artificial Intelligence in neovascular age-related macular degeneration

Klin Monbl Augenheilkd

Ferro Desideri L, Zinkernagel M, Anguita R

doi: 10.1055/a-2413-6782

Related content

Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database

Performance of artificial intelligence-based models for epiretinal membrane diagnosis: A systematic review and meta-analysis

Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes

Prototype master protocol for benchmarking of real-world follow-up data in glaucoma

Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study

The role of artificial intelligence in macular hole management: A scoping review

Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study

Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents

Artificial Intelligence in neovascular age-related macular degeneration